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There is currently no method powerful enough to identify patients at risk of developing ventricular dys-
function after myocardial infarction (MI). We aimed to identify major mechanisms related to ventricular
dysfunction to predict outcome after MI. Based on the combination of domain knowledge, protein–pro-
tein interaction networks and gene expression data, a set of potential biomarkers of ventricular dysfunc-
tion after MI was identiﬁed. Here we propose a new strategy for the prediction of ventricular dysfunction
after MI based on ‘‘network activity indices” (NAI), which encode gene network-based signatures and dis-
tinguishes between prognostic classes. These models outperformed prognostic models based on standard
differential expression analysis. NAI-based models reported high classiﬁcation accuracy, with a maxi-
mum area under the receiver operating characteristic curve (AUC) of 0.75. Furthermore, the classiﬁcation
capacity of these models was validated by performing evaluations on an independent patient cohort
(maximum AUC = 0.75). These results suggest that transcriptional network-based biosignatures can offer
both powerful and biologically-meaningful prediction models of ventricular dysfunction after MI. This
research reports a new integrative strategy for identifying transcriptional responses that characterize car-
diac repair and for predicting clinical outcome after MI. It can be adapted to other clinical domains, such
as those constrained by small molecular datasets and limited translational knowledge. Furthermore, it
may reﬂect clinically-meaningful synergistic effects that cannot be identiﬁed by standard analyses.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Despite timely reperfusion therapy with balloon angioplasty or
thrombolysis, a signiﬁcant proportion of patients with acute myo-
cardial infarction (MI) still develop left ventricular dysfunction and
heart failure. This is associated with adverse clinical outcome [1].
Reperfusion of myocardial tissue is abnormal in these patients de-
spite successful restoration of epicardial coronary blood ﬂow. Dys-
function of the microvascular bed is the major mechanism behind
abnormal tissue reperfusion in the setting of MI, and it is believed
that angiogenic factors may restore microcirculation after reperfu-
sion [2]. Indeed, several angiogenic factors have been measured in
patients with acute coronary syndromes and levels of VEGF were
found to predict prognosis [3]. In addition, it was observed thatll rights reserved.
ting characteristic curve; cT,
ntology; LOO-CV, leave-one-
network activity index; PPI,
ardiovascular Research, Re-
ute d’Arlon L-1150, Luxem-
zuaje).cardiac repair after cell transplantation is dependent on the pres-
ence of VEGF [4].
However, these observations and traditional biomarker discov-
erymethods arebasedon standard statisticalmodels and lists of bio-
markers assumed to be independent of one another. Despite their
relevance, they still focus on the behavior of individual markers
based on relative expression levels across samples. This is insufﬁ-
cient to provide deeper clues into themechanisms implicated in left
ventricular dysfunction and angiogenesis after MI. This motivates
novel approaches to understand the dynamics of angiogenesis and
the prediction of ventricular dysfunction in post-MI patients.
The notion that a better understanding of clinical outcome after
MI requires the analysis of biological networks is accepted. How-
ever, integrative network-based approaches have not been ex-
plored to date. Moreover, advances will be constrained by
limited sample sizes and incomplete knowledge encoded in these
networks. To address this challenge, we report how the integrated
analysis of a network of protein–protein interactions (PPI), large-
scale gene expression data from blood samples of patients with
normal and impaired systolic function after MI, and co-expression
networks can reveal new insights into the molecular divergence
between clinical responses after MI.
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ships have been explored in other areas. Recent studies have
mainly focused on the prediction of potential drug targets and bio-
markers in cancers. They have proposed algorithms for extracting
sub-networks implicated in disease [5–7], and the detailed re-con-
struction of regulatory networks to identify key signaling path-
ways [8]. These approaches in principle rely on relatively large
collections of gene expression data or extensive sources of anno-
tated interactions. In this paper, we assemble resources of PPI, gene
expression and transcriptional associations implicated in processes
relevant to angiogenesis in post-MI patients. Moreover, unlike pre-
vious research in post-MI ventricular dysfunction, we explore the
potential of network-based prediction models for clinical deci-
sion-making support. We developed new prognostic models based
on patient-speciﬁc expression synchronization of a small number
of genes. These models capture network-based prognostic signa-
tures, which are deﬁned as ‘‘activity indices” and provide the basis
for a novel prognostic strategy.2. Methods
2.1. Study design and analysis framework
Our investigation consisted of four phases: data acquisition,
integrative data mining, knowledge discovery and evaluation,
and independent validation (Fig. 1). It has been suggested that
angiogenesis may play a cardioprotective role in the setting of
myocardial ischemia [4,9]. This motivated the representation of a
network of PPI relevant to angiogenesis and MI in humans (step
1, Fig. 1). Also in the ﬁrst phase, expression proﬁles of blood cells
harvested at the time of mechanical reperfusion in two groups of
16 patients each (Table S1 in Supplementary Information) was
determined using whole-genome oligonucleotide microarrays
(step 2). Peripheral blood gene expression proﬁles have previously
been used to detect allograft rejection in patients with heart trans-
plantation and found to correlate with ﬁndings of endomyocardial
biopsies [10]. Ejection fraction (EF) measured with echocardiogra-
phy using Simpson’s method, 1 month after MI, was used to clas-
sify the patients into low EF (640%; median: 35, range: 20–40)Fig. 1. Study design. See the Methods section for details. The numbers indicaor high EF (>40%; median: 63, range: 45–73) groups. Both groups
of patients were age- and sex-matched and did not differ with re-
spect to reperfusion time, ﬁnal coronary ﬂow, multivessel disease,
history of previous infarction, cardiovascular risk factors or treat-
ment. As expected, enzyme release was higher in the group of pa-
tients with impaired EF, which is consistent with impaired tissue
perfusion. Of note, 6 patients in the low EF group died (37%) and
3 developed heart failure during a 2-year follow-up, while no pa-
tient died in the high EF group and only 1 developed heart failure.
These data conﬁrm the poor prognosis associated with ventricular
dysfunction after MI.
In the second phase, clustering of the PPI network identiﬁed a
set of genes signiﬁcantly implicated in the regulation of growth
and angiogenesis (step 3). From this set of genes, those found ex-
pressed in low and high EF patients by microarrays were used to
construct co-expression networks speciﬁc to the EF groups (step
4). In the third phase, analysis of co-expression networks revealed
potentially novel prognostic models (step 5), which were tested for
their ability to classify patients into low or high EF groups (step 6).
Our models exploited the application of ‘‘network activity indices”
(NAIs) for patient classiﬁcation. Finally, using an independent data-
set obtained with multiplex PCR (step 7), classiﬁcation models
were validated (step 8).
2.2. Patients and microarrays
All patients had successful mechanical reperfusion and stenting
of the infarct artery within 12 h of chest pain onset. All patients re-
ceived Aspirin, Clopidogrel, Heparin and Abciximab. Two groups
consisting each of 16 patients exhibiting different clinical outcome
after MI were analyzed (Table S1 in Supplementary Information).
One group of patients had a preserved left-ventricular (LV) systolic
function and high EF 1-month after MI (>40%, median: 63%, range:
45–73), and the other group showed impaired LV function and low
EF (640%, median: 35%, range: 20–40). Total RNA was extracted
from whole-blood cells by the PAXgene™ technology. A common
reference RNA (Universal Human Reference RNA, Stratagene Eur-
ope, Amsterdam, The Netherlands) was used in conjunction with
patient’s RNA. Messenger RNAs were ampliﬁed using the Amino
Allyl MessageAmp™ kit (Ambion, Cambridgeshire, United King-te the sequential order in which the different tasks were implemented.
814 F. Azuaje et al. / Journal of Biomedical Informatics 43 (2010) 812–819dom). Five microgram of each amino allyl aRNA were labeled with
Cy3 or Cy5 (Amersham, Buckinghamshire, United Kingdom).
750 ng of each labeled amino allyl aRNA (reference RNA or donor
RNA) were combined and hybridized on four whole-genome oligo-
nucleotide microarrays [11]. Spot ﬁnding and raw data quantiﬁca-
tion of microarrays were performed using the MAIA freeware
[12]. A Lowess non-linear normalization step was performed with
the Acuity software (Molecular Devices, Berks, UK). A ﬁltering
step was then performed to remove genes that were not present
in at least three microarrays out of four. Filtering analysis was per-
formed using the Signiﬁcance Analysis of Microarrays (SAM) soft-
ware which correlates gene expression with an external variable,
such as the EF group [13]. Missing-value imputation was per-
formed via a K-Nearest Neighbor algorithm normalization using
10 neighbours. Gene expression data are available at the GEO data-
base under the accession number GSE11947 [14].
2.3. Independent cohort and multiplex PCR data
The independent cohort consisted of 62 patients with MI (Table
S3 in Supplementary Information). From these, two groupswere re-
trieved: one group with low EF 1-month after MI (640%, median:
38%, range: 17–40) and one groupwith preserved EF (>40%,median:
55%, range: 42–86). One microgram of total RNA extracted from
whole-blood cells by the PAXgene™ technology was reverse-tran-
scribed using the Superscript II reverse transcriptase (Invitrogen,
Merelbeke, Belgium). Compatibleﬁve-plexPCRprimers anddual-la-
beled probes designed with the PrimerPlex software (Premier Bio-
soft, Palo Alto, USA) were purchased from TIB MolBiol (Berlin,
Germany) (Supplementary Information). Using the GeNorm algo-
rithm (PrimerDesign, Southampton, UK), SF3a1 was determined as
housekeeping gene for normalization. The ﬂuorophores for probe
labeling were selected to prevent emission spectra overlaps. PCR
was performed in a total volume of 20 ll containing: 1X PCR buffer
II (Applied Biosystems, Halle, Belgium), 5 mMMgCl2, 2.5 U AmpliT-
aq Gold DNA Polymerase (Applied Biosystems), 300 lM dNTPs
(Invitrogen), 4 ll of 1/10 dilutions of cDNA and primers/probes
(Supplementary Information). Multiplex quantitative real-time
PCR was performed using the IQ5 thermocycler (Biorad, Nazareth,
Belgium). After initial denaturation for 7.5 min at 95 C, 50 cycles of
20 s at 95 C and 1 min at 60 C were performed. Each run included
negative controls and a common control cDNA to check for inter-run
variability. Expression levels were calculated by the DCt method
using the housekeeping gene as reference.
2.4. Protein–protein interaction network construction and clustering
analysis
The Entrez-Gene database [15] was used to retrieve a set of core
genes known to be associated with angiogenesis in MI, using the
keywords ‘‘human, heart, angiogenesis, myocardial, infarction”.
Annotated PPI associated with these genes were retrieved from
the Human Protein Reference Database together with other inter-
acting proteins not included in the set of core genes [16]. The net-
work was visualized and analyzed with Cytoscape [17]. A network
clustering analysis was implemented to identify potential func-
tional network modules. Clusters were identiﬁed by the (Cytoscape
plug-in) MCODE network clustering algorithm [18]. Analyses of the
signiﬁcance of functional roles over-represented in these clusters
were implemented with Fatigo under the Babelomics platform
[19].
2.5. Construction and analyses of gene co-expression networks
Gene expression networks were constructed and analyzed with
BioLayout Express3d [20]. Gene co-expression was calculated withthe Pearson correlation coefﬁcient. Results were unaffected when
using the Spearman Rank correlation. The integration of gene
expression data and co-expression networks was implemented
with Cytoscape [17].2.6. Statistical analysis and software tools
Comparisons between groups were performed with the Sigma-
Plot (v11.0) and the Statistica (v8.0) software. Statistical hypothe-
sis testing on continuous numerical data were implemented with
two-tailed t-tests. Proportions were compared using two-tailed
Fisher’s exact tests. P values <0.05 were considered as statistically
detectable. P values for the associations between network clusters
and GO terms were estimated with (two-tailed) Fisher’s exact tests
and corrected to account for multiple-hypotheses testing using the
Benjamini & Hochberg adjustment procedure [19]. Classiﬁers were
built and evaluated with the Weka system [21].3. Results
3.1. Assembling and clustering analysis of a PPI network
Based on the assumption that angiogenesis may beneﬁt tissue
perfusion after MI, a PPI network of angiogenesis in human MI
was established. The network was constructed by ﬁrst extracting
from the Entrez-Gene database [15] a set of 35 genes known to
be relevant to angiogenesis and human MI (Material and Methods,
and Data S1). PPIs associated with these 35 genes were obtained
from a database of curated PPIs (Methods). The resulting network
consisted of 556 nodes (proteins) and 686 edges (interactions)
(Fig. S1 in Supplementary Information).
Clustering analysis of this network using different clustering
parameters consistently identiﬁed a sub-network with 53 proteins
highly specialized in growth regulation processes, as deﬁned in the
Gene Ontology (GO) [22]. This motivated us to deﬁne it as the
‘‘growth and regulation” module (Data S2). Of the initial set of 35
angiogenesis proteins, only 3 proteins (CTGF, TGFB1 and VEGFA)
were included in the cluster of 53. Among the genes encoding
these 53 proteins, 33 genes were expressed in the blood samples
as shown by our microarray analysis, and among these 33 genes,
VEGFB and THBS1 were found differentially expressed between
low and high EF patients as detected by SAM. In the PPI network,
VEGFB only interacts with VEGFA, while THBS1 interacts with
TGFB1 and MMP9. Subsequent analyses focused on this set of 33
genes.3.2. Construction of co-expression networks
Co-expression networks speciﬁc to each EF class were assem-
bled. High EF and low EF networks were created using samples
belonging to the corresponding class only. Nodes and edges repre-
sent genes and co-expression, respectively, above a speciﬁed corre-
lation threshold (cT). Class-speciﬁc networks were constructed for
different cT values. The number of nodes, edges and average con-
nectivity kept constant for cT < 0.75 (Fig. S2 in Supplementary
Information). Because of this and our interest in strong relation-
ships, subsequent analyses concentrated on networks with
cTP 0.75. Their small sizes, i.e. the low number of genes and inter-
actions they contain, also make them suitable for prognostic
interpretation.
Fig. 2 depicts the high EF and low EF networks obtained with
cT = 0.75, 0.80, 0.85. Differential expression synchronization pat-
terns were found suggesting that clinical outcome after MI is
linked to a speciﬁc coordination of gene expression. Relative tight
Fig. 2. Clinical outcome after MI is linked to a speciﬁc coordination of gene expression. Low and high EF patients are differentiated on the basis of gene expression
synchronization. In these networks nodes and edges represent genes and their co-expression, respectively. An edge is established between two genes when their co-
expression values are greater than the speciﬁed correlation threshold (cT). Co-expression networks for different cT show that expression of selected genes is differently
coordinated between low and high EF patients. In patients with high EF, expression of TNXB and LTBP4, as well as DAXX and VEGFB, was synchronized at the time of
reperfusion. In patients with low EF, this synchrony was lost.
Fig. 3. GO biological processes in which strong co-expression exist between the
genes from Fig. 2. Grey squares indicate enriched GO category. All terms shown
reported statistically detectable enrichments with P < 0.05, after correcting for
multiple-testing. Statistical signiﬁcance of the enrichments were estimated with
(two-tailed) Fisher’s exact tests and corrected with the Benjamini & Hochberg
adjustment procedure [19].
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TNXB and LTBP4 on the other hand, exist in the high EF category.
A correlation reduction was observed in the low EF group. Among
the four potential biomarkers, only VEGFB was signiﬁcantly differ-
entially expressed (t = 3.35, P = 0.004). The other biomarkers did
not show differential expression between low and high EF patients
(P > 0.05). In high EF samples, the correlation between VEGFB and
DAXX was equal to 0.78 (partial correlation controlling for the
other gene pair, P < 0.05, 95% conﬁdence interval (CI): [0.46,
0.93]). In low EF samples, their partial correlation was reduced to
0.29 (P > 0.05, CI: [0.69, 0.25]). With regard to TNXB and
LTBP4: in high EF samples, their partial correlation was 0.81
(P < 0.05, CI: [0.53, 0.94]), and in low EF was 0.71 (P < 0.05, CI:
[0.33, 0.90]). These four potential biomarkers do not interact be-
tween them in the global PPI network. Each one has one interacting
partner only: VEGFB with VEGFA, DAXX with TGFB1, TNXB with
VEGFA, and LTBP4 with TGFB1. These observations motivated us
to further explore the use of the pair-wise expression values of
these genes to distinguish between EF classes.
3.3. Functional analysis of co-expression networks
A closer look at the composition of the co-expression networks
showed functional differentiation. Fig. 3 shows examples of biolog-
ical processes consistently over-represented in each EF class, as de-
ﬁned in the GO. All terms shown reported statistically detectable
enrichments with P < 0.05, after correcting for multiple-testing,
with the Fatigo system [19]. In high EF samples, there is a strong
co-expression between genes involved in cell communication, bio-
genesis and growth regulation. A signiﬁcant deregulation of
growth was detected in low EF samples. Moreover, strong coordi-nation is activated between genes implicated in processes such
as collagen metabolism and transmembrane receptor protein ser-
ine/threonine kinase signaling (Fig. 3). These perturbations allow
one to propose an alternative characterization of the phenotypic
divergence observed after MI. Fig. 4 depicts how genes involved
in key biological processes appear to be kept in sync after MI,
which may either prevent or lead to ventricular dysfunction.
Fig. 4. Visualization of molecular mechanisms driving phenotypic divergence after
MI: biological processes in which genes are kept in sync (or out of sync) after MI,
which leads to either cardiac repair or ventricular dysfunction responses.
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Acrucial question iswhether theEF class canbepredicted in apa-
tient-speciﬁc context. A possible approach is thematching between
a sample and the obtained networks. To address this challenge, we
mapped the 32 samples independently on each of the relevant net-
works shown in Fig. 2. In Fig. 5 an expression level in a sample is re-
ﬂected by using a color-coded scale from green (low) to red (high
expression) relative to the genes shown in the network. This and
the network connectivity offered a method to compare associations
in a sample in relation to an EF-speciﬁc network. Thus, for amapped
sample, linkednodes showing similar colors indicate good coordina-
tion between the genes in the mapped sample. On the other hand,
linked nodes showing dissimilar colors indicate poor gene co-
expression in the mapped sample (Fig. 5).
When samples from the high EF group are mapped onto high EF
networks, between-node correlation is also reﬂected on the basis
of the color-coded scheme (e.g. upper-left network, Fig. 5). WhenFig. 5. Expression data from high (upper row) and low EF (lower row) patient mapped o
sample are plotted on the network nodes based on a color scale. Color scale is determin
expression). Linked nodes showing similar colors indicate good coordination between the
co-expression in the mapped sample. cT = 0.8 for all the networks. This Fig. illustrates
expression and co-expression on the different class-speciﬁc networks. It also suggests tha
to distinguish individuals from both classes. (For interpretation of the references to colothese samples are mapped onto low EF networks, between-node
correlation is lost, as reﬂected by greater color dissimilarity be-
tween node pairs (e.g. upper-right network, Fig. 5). An inverted
relation, based on the same interpretation approach, was found
in low EF samples. This suggested that one could concentrate on
a single (class-speciﬁc) network to perform automatic sample clas-
siﬁcation. To assess the potential of this idea, we focused on the
high EF network derived with a cT = 0.8 (left column, Fig. 5). This
is also suitable because of the small number of nodes and links.
3.5. Network-based prognostic classiﬁcation
We then investigated the feasibility of an automated computa-
tional approach to classiﬁcation, which integrates expression and
co-expression information extracted from the 4-gene network.
This task required ﬁnding answers to the following questions:
which quantitative measurements may be used to summarize
the different patient-speciﬁc networks, and can such a quantitative
measure be used to differentiate between patient classes?
Here we proposed NAIs as the basis for potential alternative pa-
tient classiﬁcation strategies. The idea is to quantify, for a given pa-
tient, the levels of expression and co-expression of the four genes
in the context of the high EF network. To implement this idea, dif-
ferent statistic scores that combine the four expression values can
be implemented. In this study we report three NAIs, which are de-
ﬁned as follows:
NAI 1 ¼MðdTþL;dVþDÞ ð1Þ
NAI 2 ¼MðdTL;dVDÞ ð2Þ
NAI 3 ¼MðdMðT; LÞ;dMðV;DÞÞ ð3Þ
with ‘‘M” representing the mean operator. In Eq. (1), dT+L and
dV+D represent the sum of expression values of TNXB and LTPB4
and the sum of expression values of VEGFB and DAXX, respectively.nto the EF class-speciﬁc co-expression networks: The expression levels from a given
ed by expression values obtained by microarrays: green (low expression), red (high
genes in the mapped sample. Linked nodes showing dissimilar colors indicate poor
how samples originating from different EF classes produce differential patterns of
t the use of one of the class-speciﬁc networks (i.e. the high EF network) can be used
r in this ﬁgure legend, the reader is referred to the web version of this article.)
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between TNXB and LTPB4, and dV-D is the difference of the expres-
sion values of VEGFB and DAXX. In Eq. (3), dM(T,L) represents the
mean expression value of TNXB and LTPB4, and dM(V,D) is the mean
expression value of VEGFB and DAXX. These indices encapsulate
quantitative gene pair-wise relationships that are potentially rele-
vant to capture between-class differences at the transcriptional
level.
Different classiﬁcation models, such as logistic regression and
support vector machines models, were implemented using these
indices as inputs. Fig. 6 and Table S2 in Supplementary Information
shows representative results fromthesemodels, togetherwithother
standard approaches based on gene expression data only. The high-
est performancewas obtained by using (cut-off) values of NAI-1 and
NAI-3 independently (leave-one-out cross-validation, LOO-CV, area
under the receiving operating curve (AUC) = 0.75). Logistic regres-
sion models using those NAIs as single inputs independently re-
ported AUC values of 0.68 and 0.69, respectively. The combination
of NAI-1 and NAI-3 into a single logistic regression model produced
an AUC = 0.65. A logistic regressionmodel that integratedNAI-1 and
NAI-2 reported an AUC = 0.74. Lower prediction performance was
obtained with standard classiﬁers using gene expression data only
(linear Support Vector Machine, maximum AUC = 0.69), which was
built on nine genes selected by SAM [13]. Classiﬁers based solely
on the expression values of the four genes as input values, i.e. with-
out between-gene information, showed maximum AUC = 0.68 (lo-
gistic regression model). Although absolute differences were
observed between proposed and standard models, these were not
statisticallydetectable atP = 0.05.Apossible lackof statistical power
may be explained by the relatively small number of patients in-
cluded in this study [23,24]. Thus, future studies will require the
analysis of larger population samples.3.6. Independent validation
The obtained NAI-based prediction models were tested on an
independent dataset consisting of 62 patients not included aboveFig. 6. Representative results from NAI-based models and standard approaches. AUC: a
microarray data using LOO-CV; ind1: microarray-derived models tested on independen
independent cohort. Models: NAI-1 (cutoff-based prediction using NAI-1); NAI-3 (cutoff
NAI-2-LR (logistic regression with NAI-2 as input); NAI-3-LR (logistic regression with NAI
3-LR (logistic regression with NAI-1 and NAI-3 as inputs); 4-biomarker (logistic regres
(support vector machine built with nine genes derived from standard data-driven analy(Methods, Table S3 in Supplementary Information). Clinical charac-
teristics of these patients were undistinguishable to the previous
cohort (Table S1 in Supplementary Information) and were divided
in two groups based on their EF 1-month after MI, as previously
performed: low EF (640%; median: 38, range: 17–40) or high EF
(>40%; median: 55, range: 42–86). Classiﬁcation accuracies were
consistent, and in some cases higher, that those shown above
(Fig. 6, Table S4 in Supplementary Information). As in the micro-
array-based model analysis, the use of individual NAIs as model in-
puts was sufﬁcient to produce relative high classiﬁcation
performance (AUC = 0.75). The combination of NAI-1 and NAI-3
also reported a maximum AUC = 0.75. Moreover, NAI-based mod-
els again outperformed models whose inputs represented the gene
expression values of the four genes only, i.e. no between-gene
expression relationships were included.
As a second model validation strategy, we built and tested mod-
els on the independent evaluation dataset through LOO-CV. The
classiﬁcation performance, as estimated by AUC values, was con-
sistent with the other evaluations (Fig. 6, and Table S5 in Supple-
mentary Information). Different models based on NAI-1, NAI-2
and NAI-3 values again reported accurate prognostic capacity
(maximum AUC = 0.77).
It is worth noting that, as in the case of microarray data, reduc-
tions of gene co-expression were detected in low EF. In high EF
samples, the partial correlation between VEGFB and DAXX was
equal to 0.30 (P < 0.05). In low EF samples, their partial correlation
was reduced to 0.19 (P > 0.05). With regard to TNXB and LTBP4: in
high EF samples, their partial correlation was 0.18 (P < 0.05), and
in low EF was reduced to 0.35 (P > 0.05).4. Discussion
In this study, we integrated and analyzed: (1) a network of
interactions between proteins known to be involved in angiogene-
sis and MI, (2) gene expression data from blood samples of MI pa-
tients, and (3) associations between co-expression networks and
ventricular dysfunction after MI. These investigations led to therea under the receiver operating characteristic curve; mm: models built/tested on
t cohort; ind2: models built and tested through leave-one-out cross validation on
-based prediction using NAI-3); NAI-1-LR (logistic regression with NAI-1 as input);
-3 as input); NAI-1/2-LR (logistic regression with NAI-1 and NAI-2 as inputs); NAI-1/
sion with expression values of VEGFB, TNXB, LTBP4, DAXX as inputs); Traditional
sis, SAM method).
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of left-ventricular function, and useful to predict its status after MI.
A PPI network related to angiogenesis and MI was constructed
as a knowledge reference to guide the reduction of the biomarker
search space. Our main hypothesis was that angiogenesis may offer
protection in the setting of myocardial ischemia. The second main
assumption was that proteins linked via physical interactions are
likely to be functionally-related in specialized processes or func-
tions relevant to angiogenesis and MI. We focused our attention
on the network cluster that exhibited a high enrichment of pro-
teins involved in the regulation of angiogenesis. Our hypothesis
was that this cluster could contain potential primary drivers of
angiogenesis in the context of MI. We went beyond the analysis
of well-characterized angiogenesis-related genes to search for
potentially novel biomarkers linked to both angiogenesis and ven-
tricular dysfunction.
Matching of co-expression networks to EF classes, i.e. to pre-
served LV function (high EF) or failure (low EF), identiﬁed four
main candidates, VEGFB, DAXX, TNXB and LTBP4. These proteins
are either involved in angiogenesis, apoptosis or in the processing
of the extracellular matrix. VEGFB is a member of the VEGF family
of growth factors and its involvement in the recovery of the heart
after ischemia has been evidenced using VEGFB-deﬁcient mice
[25]. DAXX interacts with several proteins involved in cell death,
although its precise role in apoptosis is still unclear [26]. TNXB
plays a causative role in Ehlers–Danlos syndrome through regula-
tion of collagen deposition by ﬁbroblasts [27]. LTBP4 is involved in
the turnover of the extracellular matrix and in ﬁbroblast adhesion
[28].
This investigation offers clinically-relevant insights into the
reprogramming of patient-speciﬁc transcriptional networks, which
may prompt the occurrence of ventricular dysfunction. Co-expres-
sion networks characterizing high and low EF samples were iden-
tiﬁed, which are differentiated by structural and functional
features. This allowed visualization of a transcriptional circuitry
reconﬁguration distinguishing clinical outcomes after MI. Among
different responses, activation of collagen metabolic processes, to-
gether with major perturbations of cell proliferation and growth
regulation, are triggered along the route leading to low EF. Indeed,
the most striking difference between high and low EF patients re-
lates to regulation of growth. Whereas high EF patients display a
relatively strong co-expression between genes involved in growth
regulation, this co-expression seems to be lost in low EF patients.
This observation is consistent with cell growth as a natural repair
mechanism of the heart after MI. In addition, we noted a signiﬁcant
coordination between genes implicated in collagen metabolism in
the low EF group, presumably in relation to an excessive synthesis
of collagen which can lead to ﬁbrosis.
The expression relationships between VEGFB, DAXX, TNXB and
LTBP4 have prognostic value in the majority of the samples in-
cluded here. Information extracted from the gene co-expression
interplay of these four genes allowed us to built classiﬁcation mod-
els with AUC > 0.70 in different cross-validation and independent
evaluation scenarios. The NAI-based models proposed here repre-
sent a potentially novel network-based approach to classiﬁcation,
which does not rely on information obtained from individual genes
or their expression values independently.
One of the possible limitations of this study is the relatively
small amount of samples. However, it should be stressed that our
proposal of combining different knowledge and data resources
was conceived in response to this reality, as well as the limited
power associated with single data sources. Despite the limited
amount of data, novel testable insights have been provided regard-
ing the evolution of ventricular dysfunction after MI. We also dem-
onstrated how quantitative and qualitative evidence can be used to
design new and relatively powerful prognostic methodologies in areal clinical environment, including the application of cost-effec-
tive PCR multiplex assays.
Another critical aspect is the known limits of using protein/gene
networks for predictive data mining as argued by Hakes et al. [29].
In this investigation, nevertheless, the PPI represented a knowl-
edge reference to guide subsequent analyses. Such a framework al-
lowed us to focus our attention on a relatively small group of
proteins based on their relevance to post-MI processes. Our main
hypothesis was that angiogenesis may play a cardioprotective role
in the setting of myocardial ischemia. The initial set of 35 genes is
known to be involved in angiogenesis and was used as the ‘‘seed
list” of the PPI network construction. We acknowledge that this
may be a relatively small number for knowledge discovery. How-
ever, the network construction process expanded the biomarker
search space to more than 500 genes. Moreover, the new biomark-
ers proposed here were not included in the seed list of genes. Other
PPI databases could have been analyzed in the implementation of
the approach presented here. We chose the HPRD because it has
become a well-known resource for supporting network-based
knowledge discovery in different biomedical domains. HPRD also
offers a relative large number of PPIs obtained from in vivo and
in vitro methods. Furthermore, HPRD has become a community-
driven database [30], which in addition is currently used by key
biological knowledge resources, such as Entrez-Gene, STRING and
the MSigDB [30]. The use of multiple databases may have contrib-
uted to the representation of a more comprehensive, though not
necessarily more ‘‘accurate”, network of PPIs related to angiogene-
sis. However, we aimed to construct the PPI network as a resource
to guide the search for potentially relevant biomarkers.
By concentrating on ﬁrst-interacting partners we may have
missed potential biologically-meaningful interactions. Neverthe-
less, an emphasis on ﬁrst-interacting partners is also a strategy
to reduce the number of potential false positive interactions, i.e.
spurious associations in the context of angiogenesis and MI in hu-
mans. Our main objective was to focus our attention on proteins
and interactions with potential signiﬁcant roles in angiogenesis
after MI. Also, it is important to stress that the different networks
reported here were not used to infer topological motifs or un-
known relationships with potential functional relevance. We also
recognize that it would be possible to propose more sophisticated
methods for reconstructing co-expression networks [31]. However,
the aim of this study was not to present a detailed view of the tran-
scriptional regulatory architecture in each clinical class. In any
case, even if required, such level of resolution would not be possi-
ble based on the number of samples available and the lack of time-
dependent data. Our main goal was to identify major, global differ-
ential patterns between patient groups using co-expression
information.5. Conclusions
In summary, we propose a new strategy for analyzing differen-
tial transcriptional responses after MI, and for classifying patients
on the basis of both gene expression and co-expression signatures.
This proof-of-concept study is compatible with ongoing efforts to-
wards personalized medicine. It may aid clinicians in deﬁning pri-
orities for treatment or prevention of ventricular dysfunction post-
MI, and drug developers in identifying participants for clinical tri-
als. Another advantage is the capacity to detect a small number of
potential biomarkers, whose integrated expression coordination is
altered in patients exhibiting complications after MI.Competing interests
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